2 not yet recruiting, 1 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 2 |
Follow Azurity Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures Zonisamide Oral Product - Seizures, Seizures, Focal | Phase 4 | Not yet recruiting | Azurity Pharmaceuticals | 40 | 2026-09-01 | 2026-09-15 |
| Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men Testosterone Cypionate Injection 200 mg/mL - Hypogonadism, Male | Phase 4 | Not yet recruiting | Azurity Pharmaceuticals | 144 | 2026-02-01 | 2026-01-09 |
| The Mycophenolate Pregnancy Registry Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases | Completed | Genentech, Inc. | 400 | 2012-11-20 | 2026-10-13 |
Autoimmune Diseases (1) · Epilepsies, Partial (1) · Epilepsy (1) · Eunuchism (1) · Seizures (1)
testosterone 17 beta-cypionate (1)
United States (3)